retatrutide legal status A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Clinical Pharmacology Eli Lilly Preparing Retatrutide Applications

While its generally less common than other GI side effects, constipation may hang around longer and be more disruptive for some

Metformin offers proven cardiovascular benefits, weight neutrality or modest weight loss, and an excellent safety profile

GLP-1 medications that prevent or delay these outcomes can be cost-effective even at higher price points, which is the argument payers are increasingly accepting

1, 2022, to Dec

Unlike many hypoglycemic drugs, GLP-1 regulates glucose levels in a glucose-dependent manner, significantly reducing the risk of hypoglycemia

How can we refine our marketing and messaging that speaks to current needs